Innovative treatments

New technology should be assessed—not simply promoted.

RDN, PFA, MRgFUS and TAVR may be relevant for selected patients, subject to evidence, eligibility and access.

Speak With a Care CoordinatorNo form. No medical-record upload. No online diagnosis.

Innovative treatments

What this page helps you understand

RDN, PFA, MRgFUS and TAVR may be relevant for selected patients, subject to evidence, eligibility and access.

01

Clinical indication before technology

02

Benefits, risks and alternatives

03

Availability must be reconfirmed

What happens next

What happens next

01

Start with a general conversation—without sending medical records.

02

A coordinator explains what information may be needed and the approved secure channel.

03

Relevant providers confirm acceptance, requirements, timing and quotation individually.

Clear medical boundaries

Information on this page is general and does not replace assessment by a qualified clinician. Acceptance, timing, price and outcomes cannot be guaranteed.

Medical Disclaimer

What happens next

Speak With a Care Coordinator

No form. No medical-record upload. No online diagnosis.

Speak With a Care Coordinator